Beta: Sign in
Shares outstandingAs of 2026-07-27 · filed common shares: 51.73M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 3.21%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 11.27%
Short ratioDays to cover, as published by FINRA: 4.83
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 62.00%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 56.20%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for CDNA

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginTTM to Jun 26: 23.61%
Net margin: —
EBITDA marginTTM to Jun 26: 26.75%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 29.49%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 22.72%

Growth

Revenue growth (annual YoY): 13.79%
Revenue growth (latest qtr YoY): 52.23%
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Dec 25 vs FY Dec 24: -140.64%
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): 3838.63%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: 2.08
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $373.63M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $19.24M
Debt / equityas of Jun 26: 4.52%
Current ratioas of Jun 26: 4.58
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 4.35
Operating cash flowTTM to Jun 26: $93.65M
Free cash flow (six months)Six months: 2026-01-01 to 2026-06-30 · Not annualized: $29.26M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 8.72

CDNA stock Statistics — CareDx, Inc. filings, insiders & smart money · Instaport